
|Videos|October 6, 2017
What Are the Results of the REVIVE-2 Trial?
Author(s)Contagion® Editorial Staff
David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
Advertisement
David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Measles Update: February 6, 2026
2
Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus
3
HIV in the Black Community: Shifting from Stigma and Health Inequalities to Communication and Care Initiatives
4
Antibiotics Deconstructed: IV Fosfomycin
5
































































































































